Publizoom

Award notice Supplies

2023/0491 - Ixecizumab [80 mg/1 ml sol inj caneta]

Notice published in Portuguese. The AI analysis summarises it for you in your language.

Public buyer
Unidade Local de Saúde Santa Maria, E.P.E.
Lisboa
Place of performance
Lisboa
Estimated value
€850,322 excl. VAT
Amount awarded
€850,322 excl. VAT
Planned end of contract
5 January 2027
likely re-tender around October 2026
Bids received
1
Form
Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure
Restricted procedure
You first submit an application; only shortlisted candidates are invited to bid.
Publication
21 July 2026
Notice language
Portuguese

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

IXECIZUMAB [80 MG/1 ML SOL INJ CANETA

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€247,856
Median
€358,774
A quarter above
€902,500

Amounts awarded (excl. VAT) over the last 3 years for 49 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
2026/0006 - Carfilzomib [60 mg pó sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026
AMGEN BIOFARMACEUTICA, LDA €655,674
2026/0006 - Olaparib [150 mg cáp/ comp]
Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026
ASTRAZENECA- PROD.FARM LDA €266,176
2026/0098 - Agalsidase beta [35 mg f/amp]
Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026
SANOFI-PRODUTOS FARMACÊUTICOS,LDA €252,123
2024/0782 - Dexametasona [700 µg impl intravítreo emb]
Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026
ABBVIE, LDA €258,751
2026/0006 - Lorlatinib [100 mg cáp/ comp]
Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026
LAB. PFIZER, LDA €55,301

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 503377-2026.